The Combination TAB004 + Lip-MSA-IL-2 Treatment Led to Significant Increases in Circulating Levels of CXCL1 and IL-5 as Well as Decreased IL-6 in the Sera of KCM Tumor Bearing MUC1.Tg Mice. Here, IL2 is linked to neoplasm.